Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
VASCULAR SOLUTIONS INC (VASC)
|
Add to portfolio |
|
|
|
| Price: |
$55.95
| | Metrics |
| OS: |
17.5
|
M
| |
9
|
% ROE
|
| Market cap: |
$981
|
M
| |
13
|
% ROIC
|
|
Net cash:
|
$39.1
|
M
| |
$2.23
|
per share
|
|
EV:
|
$942
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$20.0
|
M
| |
47.2
|
x EV/EBITDA
|
|
EBIT
|
$13.4
|
M
| |
70.5
|
x EV/EBIT
|
| EPS |
$0.68
| |
81.9
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 147.2 | 126.1 | 110.5 | 98.4 | 90.0 | 78.4 | 68.4 | 61.2 |
| Revenue growth | 16.7% | 14.1% | 12.3% | 9.4% | 14.7% | 14.6% | 11.8% | 15.8% |
| Cost of goods sold | 49.0 | 41.9 | 36.2 | 32.6 | 29.8 | 26.6 | 23.8 | 20.7 |
| Gross profit | 98.2 | 84.2 | 74.3 | 65.8 | 60.1 | 51.8 | 44.7 | 40.5 |
| Gross margin | 66.7% | 66.8% | 67.2% | 66.9% | 66.8% | 66.0% | 65.3% | 66.2% |
| Sales and marketing | 34.1 | 29.8 | 27.4 | 25.8 | 24.1 | 23.2 | 21.2 | 20.5 |
| Research and development | 18.4 | 13.4 | 13.2 | 11.9 | 10.2 | 9.5 | 7.8 | 6.3 |
| General and administrative | 22.6 | 13.0 | 9.0 | 6.5 | 5.0 | 5.2 | 4.6 | 4.7 |
| EBITA | 15.2 | 21.6 | 17.7 | 17.3 | 16.4 | 13.9 | 8.2 | 4.5 |
| EBITA margin | 10.3% | 17.1% | 16.0% | 17.6% | 18.3% | 17.7% | 11.9% | 7.3% |
| Amortization of intangibles | 1.6 | 1.6 | 1.6 | 1.4 | 0.8 | 0.3 | | |
| EBIT | 13.6 | 19.9 | 16.1 | 15.9 | 15.6 | 13.6 | 8.2 | 4.5 |
| EBIT margin | 9.2% | 15.8% | 14.6% | 16.2% | 17.3% | 17.3% | 11.9% | 7.3% |
| Pre-tax income | 13.6 | 19.9 | 16.1 | 15.9 | 15.7 | 13.6 | 8.2 | 3.1 |
| Income taxes | 3.2 | 7.2 | 4.9 | 6.0 | 6.0 | -7.8 | 2.8 | -13.0 |
| Tax rate | 23.3% | 36.0% | 30.7% | 37.6% | 38.0% | | 34.1% | |
| Net income | 10.5 | 12.7 | 11.1 | 9.9 | 9.7 | 21.4 | 5.4 | 16.2 |
| Net margin | 7.1% | 10.1% | 10.1% | 10.1% | 10.8% | 27.3% | 7.9% | 26.4% |
| |
| Diluted EPS | $0.58 | $0.72 | $0.65 | $0.60 | $0.57 | $1.26 | $0.33 | $1.01 |
| Shares outstanding (diluted) | 18.0 | 17.7 | 17.0 | 16.5 | 17.2 | 17.0 | 16.5 | 16.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|